Which nasal cannula keeps oxygen levels safer during ERCP?

NCT ID NCT07611903

Recruiting now Symptom relief Sponsor: Kocaeli University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This study compares two oxygen delivery devices—high-flow nasal cannula and Microstream Advance nasal cannula—during ERCP, a procedure done under deep sedation. The goal is to see which one better prevents oxygen desaturation. 74 adults scheduled for ERCP will be randomly assigned to one of the two devices, and researchers will track oxygen levels and complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: High-flow nasal cannula and Microstream Advance nasal cannula
What this could lead to: If one device works better, it could help prevent dangerous drops in oxygen during ERCP procedures, making them safer.
What could go wrong: This is a small, early-stage study with only 74 people, so results may not apply to everyone. Both devices are already in use, so no major breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypoxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY HYPOXEMIA

Contacts and locations

Locations

Kocaeli University Faculty of Medicine Hospital
RECRUITING

Kocaeli, Umuttepe, 41100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.